Your browser doesn't support javascript.
loading
Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer.
Chen, Baomin; Zheng, Donghua; Yu, Weiguang; Huang, Cuiping; Ye, Junxing; Han, Guowei; Zhuang, Jintao.
Affiliation
  • Chen B; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zheng D; Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Yu W; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Huang C; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Ye J; Department of Orthopaedics, The Third People's Hospital of Wuxi, Jiangsu Province; The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
  • Han G; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhuang J; Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
J Int Med Res ; 48(9): 300060520930440, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32993393

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Limits: Female / Humans Language: En Journal: J Int Med Res Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Limits: Female / Humans Language: En Journal: J Int Med Res Year: 2020 Document type: Article